Naprosyn Entero (Naproxen)

Naproxen, the active ingredient in Naprosyn Entero, is a Nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It is used to relieve pain and inflammation in a variety of musculoskeletal conditions and is prescribed for adults who need sustained anti‑inflammatory therapy.

GNH USA supplies Naprosyn Entero as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naproxen is an NSAID that reduces inflammation and pain in several rheumatic and musculoskeletal disorders. - Pain: provides symptomatic relief of mild to moderate acute pain. - Rheumatoid arthritis: decreases joint swelling, stiffness and pain. - Osteoarthritis: improves mobility and reduces chronic joint discomfort. - Ankylosing spondylitis: alleviates spinal inflammation and stiffness. - Gout flares: lessens acute inflammatory pain associated with gout attacks.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Dyspepsia: upset stomach or indigestion. - Headache: mild to moderate head pain. - Dizziness: sensation of light‑headedness. - Nausea: feeling of queasiness. - Diarrhoea: loose stools. - Peripheral oedema: mild swelling of the lower limbs.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Renal impairment: reduced kidney function. - Hepatotoxicity: liver enzyme elevation. - Cardiovascular events: increased risk of heart attack or stroke. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Anaphylaxis: rare but potentially life‑threatening allergic response.

Before initiating therapy, consider patient‑specific risk factors and monitor appropriately. - Cardiovascular risk: assess history of heart disease before use. - Gastrointestinal history: avoid in patients with active ulcers or severe GI bleeding. - Renal function: monitor creatinine in patients with pre‑existing kidney disease. - Hepatic disease: use cautiously in liver impairment. - Concomitant anticoagulants: increase bleeding risk; monitor coagulation parameters. - Store at ambient temperature: keep below 25 °C, retain in original container, protect from moisture and direct sunlight.

Naproxen may interact with several drug classes, requiring vigilance.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened bleeding risk. - Selective serotonin reuptake inhibitors (SSRIs): increased gastrointestinal bleeding. - Other NSAIDs or COX‑2 inhibitors: additive renal and GI toxicity. - Methotrexate: reduced clearance leading to toxicity. - Lithium: elevated serum lithium levels.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in renal function. - Diuretics: risk of reduced kidney perfusion. - Corticosteroids: synergistic GI ulcer risk. - Antihypertensives: may blunt blood‑pressure‑lowering effect. - Oral hypoglycemics: potential alteration of glucose control.